1. A decade of progress in juvenile idiopathic athritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry;Nguyen;Rheumatology (Oxford),2024
2. Greater DMARD use, improved clinical but not patient-reported outcomes in juvenile idiopathic arthritis: what are we missing?;Shoop-Worrall;Rheumatology (Oxford),2024
3. Genetic changes from type I interferons and JAK inhibitors: clues to drivers of juvenile dermatomyositis;Covert;Rheumatology (Oxford),2024
4. Revealing novel genomic insights and therapeutic targets for juvenile idiopathic arthritis through omics;Fan;Rheumatology (Oxford),2024
5. Molecular diagnostic yield for Blau syndrome in previously diagnosed juvenile idiopathic arthritis with uveitis or cutaneous lesions;Zhong;Rheumatology (Oxford),2024